Pyridoxylamine (dihydrochloride)
Pyridoxylamine dihydrochloride is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions[1].
Product Specifications
CAS Number
524-36-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pyridoxylamine-dihydrochloride.html
Concentration
10mM
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
OCC1=C(CN)C(O)=C(C)N=C1.[H]Cl.[H]Cl
Molecular Formula
C8H14Cl2N2O2
Molecular Weight
241.12
Precautions
H302, H315, H319, H335
References & Citations
[1]Stitt A, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002 Sep;51 (9) :2826-32.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL
TAG-72 / CA72.4 (B72.3), CF568 conjugate, 0.1mg/mL
CD50 / ICAM3 (CG106), CF594 conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF405M conjugate, 0.1mg/mL
P27 / KIP1 (SX53G8), CF740 conjugate, 0.1mg/mL
